2018
$24M
from 16 investors over 16 rounds
VERALOX Therapeutics raised $24M on June 20, 2023
Investors: Sanofi Ventures, JDRF T1D Fund, Genesys Capital, Pappas Capital and NYBC Ventures
VERALOX Therapeutics raised $17M on June 16, 2021
Investors: Sanofi Ventures, Point Field Partners, VTC Innovation Fund, JDRF T1D Fund, Genesys Capital, Maryland Momentum Fund and Alumni Ventures Group
VERALOX Therapeutics raised $5.4M on September 5, 2019
Investors: VTC Innovation Fund, Sanofi Ventures, JDRF T1D Fund and Maryland Momentum Fund